Testing an Experimental Coronavirus Vaccine

Testing an Experimental Coronavirus Vaccine

An experimental vaccine developed by the National Institute of Allergy and Infectious Diseases (NIAID) and Moderna is ready to enter human testing, announced NIAID director Anthony Fauci. This rapid response, getting a vaccine into phase I trials within three months of the sequencing of the virus, is a new record. Yourway has extensive experience in supporting accelerated clinical trials when the need is acute.

Back to Index

Upcoming Event

World Vaccine Congress Washington DC 2020

September 27-29, 2020
Washington DC



Staying Ahead of COVID-19

Open chat
Come chat with us!
Hello! How can I help you?